Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
7.31
Nov 06 • 3:59 PM ET Dollar change-0.61 Percentage change(-7.70%)
Aftermarket Close
7.35
Aftermarket • 7:30 PM ET Dollar change+0.04 Percentage change(0.55%)
Nov 05, 11:42 PMChimera book value per share falls 16.5% to $14.82 as solid EAD meets Q4 headwinds, withdraws $1.80 full-year EAD target
Index
RUT
Market Cap
611.94M
Enterprise Value
15.20B
Income
-256.18M
Sales
992.36M
Book/sh
14.81
Cash/sh
4.27
Employees
423
IPO
Nov 16, 2007
P/E
-
Forward P/E
3.66
PEG
0.87
P/S
0.62
P/B
0.49
P/C
1.71
P/FCF
-
EV/EBITDA
28.49
EV/Sales
15.32
Quick Ratio
0.05
Current Ratio
0.05
Debt/Eq
6.46
LT Debt/Eq
2.32
Option/Short
Yes / Yes
EPS (ttm)
-3.05
EPS next Y
2.00
EPS next Q
0.45
EPS this Y
12.90%
EPS next Y
5.18%
EPS next 5Y
4.19%
EPS past 3/5Y
- 53.78%
Sales past 3/5Y
7.10% 4.21%
EPS Y/Y TTM
-697.18%
Sales Y/Y TTM
19.17%
EPS Q/Q
-755.50%
Sales Q/Q
32.84%
Insider Own
2.07%
Insider Trans
0.00%
Inst Own
60.02%
Inst Trans
1.60%
ROA
-1.07%
ROE
-7.19%
ROIC
-2.37%
Gross Margin
95.07%
Oper. Margin
49.02%
Profit Margin
-25.82%
SMA20
-12.50%
SMA50
-24.43%
SMA200
-39.98%
Trades
Shs Outstand
83.71M
Shs Float
81.98M
52W High
14.18 -48.43%
52W Low
7.69 -4.94%
Volatility
5.63% 3.62%
ATR (14)
0.35
RSI (14)
26.03
Beta
1.82
Rel Volume
2.67
Avg Volume
1.28M
Volume
3,418,207
Perf Week
-11.93%
Perf Month
-18.87%
Perf Quarter
-37.57%
Perf Half Y
-46.41%
Perf YTD
-41.19%
Perf Year
-37.68%
Perf 3Y
-50.17%
Perf 5Y
-84.78%
Perf 10Y
-84.27%
Prev Close
7.92
Price
7.31
Change %
-7.70%
Consensus
Buy
Avg. Price Target
$13.00
Implied Upside
+77.8%
Analysts8incl. previous ratings
Rating Distribution2 Buy · 5 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 09, 2025Downgrade
RY logoRRBC Capital Mkts
Outperform → Sector Perform$13+77.8%
May 14, 2025Upgrade
UBS logoUUBS
Neutral → Buy$15+105.2%
Dec 06, 2023Initiated
UBS logoUUBS
Neutral$5.50-24.8%
Dec 10, 2020Downgrade
BCS logoBBarclays
Equal Weight → Underweight$9 → $10+36.8%
Oct 03, 2019Initiated
RY logoRRBC Capital Mkts
Outperform
Aug 21, 2019Downgrade
CCredit Suisse
Outperform → Neutral$19.50+166.8%
Mar 27, 2019Initiated
NNomura
Buy
Jun 15, 2018Initiated
RY logoRRBC Capital Mkts
Outperform
Jan 25, 2018Upgrade
CCredit Suisse
Neutral → Outperform
Feb 16, 2017Upgrade
WFC logoWWells Fargo
Underperform → Market Perform
Chimera Investment Corp. is a real estate investment trust, which engages in the business of investing in a portfolio of mortgage assets, including residential mortgage loans, Agency residential mortgage-backed securities (RMBS), Non-Agency RMBS, Agency commercial mortgage-backed securities (CMBS), and other real estate-related assets. It operates through the following segments: Investment Portfolio and Residential Origination. The Investment Portfolio segment consists of investments and third-party advisory services activities. The Residential Origination segment includes the stand-alone mortgage origination business. The company was founded on June 1, 2007 and is headquartered in New York, NY.
Esq.Mr. Phillip John Kardis II
CFO & Principal Accounting OfficerMr. Subramaniam Viswanathan
C.F.A.Mr. Jack Lee Macdowell Jr.
Chief Legal Officer & Corporate SecretaryMs. Miyun Sung J.D.
Head of Capital MarketsVictor Falvo